Literature DB >> 31480854

GFAP alternative splicing regulates glioma cell-ECM interaction in a DUSP4-dependent manner.

Emma J van Bodegraven1, Jessy V van Asperen1, Jacqueline A Sluijs1, Coen B J van Deursen1, Miriam E van Strien1, Oscar M J A Stassen2,3, Pierre A J Robe4, Elly M Hol1,5.   

Abstract

Gliomas are the most common primary brain tumors. Their highly invasive character and the heterogeneity of active oncogenic pathways within single tumors complicate the development of curative therapies and cause poor patient prognosis. Glioma cells express the intermediate filament protein glial fibrillary acidic protein (GFAP), and the level of its alternative splice variant GFAP-δ, relative to its canonical splice variant GFAP-α, is higher in grade IV compared with lower-grade and lower malignant glioma. In this study we show that a high GFAP-δ/α ratio induces the expression of the dual-specificity phosphatase 4 (DUSP4) in focal adhesions. By focusing on pathways up- and downstream of DUSP4 that are involved in the cell-extracellular matrix interaction, we show that a high GFAP-δ/α ratio equips glioma cells to better invade the brain. This study supports the hypothesis that glioma cells with a high GFAP-δ/α ratio are highly invasive and more malignant cells, thus making GFAP alternative splicing a potential therapeutic target.-Van Bodegraven, E. J., van Asperen, J. V., Sluijs, J. A., van Deursen, C. B. J., van Strien, M. E., Stassen, O. M. J. A., Robe, P. A. J., Hol, E. M. GFAP alternative splicing regulates glioma cell-ECM interaction in a DUSP4-dependent manner.

Entities:  

Keywords:  GFAP isoforms; cytoskeleton; extracellular matrix; glioblastoma multiforme; intermediate filaments

Mesh:

Substances:

Year:  2019        PMID: 31480854     DOI: 10.1096/fj.201900916R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  5 in total

Review 1.  GFAP Alternative Splicing and the Relevance for Disease - A Focus on Diffuse Gliomas.

Authors:  Jessy V van Asperen; Pierre A J T Robe; Elly M Hol
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

2.  GFAP splice variants fine-tune glioma cell invasion and tumour dynamics by modulating migration persistence.

Authors:  Rebeca Uceda-Castro; Jessy V van Asperen; Claire Vennin; Jacqueline A Sluijs; Emma J van Bodegraven; Andreia S Margarido; Pierre A J Robe; Jacco van Rheenen; Elly M Hol
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

Review 3.  GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma.

Authors:  Roxana Radu; George E D Petrescu; Radu M Gorgan; Felix M Brehar
Journal:  Front Oncol       Date:  2022-03-18       Impact factor: 6.244

4.  A Novel Splice Variant of BCAS1 Inhibits β-Arrestin 2 to Promote the Proliferation and Migration of Glioblastoma Cells, and This Effect Was Blocked by Maackiain.

Authors:  Yun-Hua Kuo; Huey-Shan Hung; Chia-Wen Tsai; Shao-Chih Chiu; Shih-Ping Liu; Yu-Ting Chiang; Woei-Cherng Shyu; Shinn-Zong Lin; Ru-Huei Fu
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

5.  Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients.

Authors:  Jialin Wang; Zhendong Liu; Cheng Zhang; Hongbo Wang; Ang Li; Binfeng Liu; Xiaoyu Lian; Zhishuai Ren; Wang Zhang; Yanbiao Wang; Bo Zhang; Bo Pang; Yanzheng Gao
Journal:  PeerJ       Date:  2021-02-08       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.